- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript5 days agokr18.69Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr18.69Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr18.69Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
Q4 2023 Nykode Therapeutics ASA Earnings Call Transcript
Greetings, and welcome to Nykode Therapeutics Q4 2023 financial results presentation. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Michael Engsig, CEO of Nykode. Please go ahead.
Thank you very much and to all our participants, a very warm welcome to the Q4 webcast from Micro Therapeutics, and we assume you're all familiar with the forward-looking statements of my code. And on that note, I will move on.
It's my pleasure today to be joined at this, what we call here by my colleagues, Agnete Fredriksen, Chief Business Officer and Co-Founder; Harald Gurvin, our Chief Financial Officer; as well as Klaus Edvardsen, our Chief Development Officer, who will help me guide you through the highlights of the fourth quarter and answer any questions that you may submit in the system.
So Q4 was another very exciting quarter for us with a good, solid progress for the Company, and we expanded the oncology pipeline
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)